Recombinant multi-species MCP-1/CCL2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MCP-1/CCL2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene is one of several cytokine genes clustered on the q-arm of chromosome 17. Chemokines are a superfamily of secreted proteins involved in immunoregulatory and inflammatory processes. The superfamily is divided into four subfamilies based on the arrangement of N-terminal cysteine residues of the mature peptide. This chemokine is a member of the CC subfamily which is characterized by two adjacent cysteine residues. This cytokine displays chemotactic activity for monocytes and basophils but not for neutrophils or eosinophils. It has been implicated in the pathogenesis of diseases characterized by monocytic infiltrates, like psoriasis, rheumatoid arthritis and atherosclerosis. It binds to chemokine receptors CCR2 and CCR4. Elevated expression of the encoded protein is associated with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection. [provided by RefSeq, Aug 2020]
The Alternative Names of target: C-C motif chemokine 2,CCL2,Ccl2,GDCF-2,HC11,HSMCR30,JE,MCAF,MCP-1,MCP1,Monocyte chemoattractant protein 1,Monocyte chemotactic and activating factor (MCAF),Monocyte chemotactic protein 1 (MCP-1),Monocyte secretory protein JE,SCYA2,SMC-CF,Scya2,Sigje,Small-inducible cytokine A2
Go
to MCP-1/CCL2 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T11309-Ag-1/ GM-Tg-hg-T11309-Ag-2 | Human MCP-1/CCL2 protein | Human |
| GM-Tg-rg-T11309-Ag-1/ GM-Tg-rg-T11309-Ag-2 | Rat MCP-1/CCL2 protein | Rat |
| GM-Tg-mg-T11309-Ag-1/ GM-Tg-mg-T11309-Ag-2 | Mouse MCP-1/CCL2 protein | Mouse |
| GM-Tg-cynog-T11309-Ag-1/ GM-Tg-cynog-T11309-Ag-2 | Cynomolgus/Rhesus macaque MCP-1/CCL2 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T11309-Ag-1/ GM-Tg-felg-T11309-Ag-2 | Feline MCP-1/CCL2 protein | Feline |
| GM-Tg-cang-T11309-Ag-1/ GM-Tg-cang-T11309-Ag-2 | Canine MCP-1/CCL2 protein | Canine |
| GM-Tg-bovg-T11309-Ag-1/ GM-Tg-bovg-T11309-Ag-2 | Bovine MCP-1/CCL2 protein | Bovine |
| GM-Tg-equg-T11309-Ag-1/ GM-Tg-equg-T11309-Ag-2 | Equine MCP-1/CCL2 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T11309-Ag-1/ GM-Tg-hg-T11309-Ag-2;
GM-Tg-rg-T11309-Ag-1/ GM-Tg-rg-T11309-Ag-2;
GM-Tg-mg-T11309-Ag-1/ GM-Tg-mg-T11309-Ag-2; GM-Tg-cynog-T11309-Ag-1/ GM-Tg-cynog-T11309-Ag-2; GM-Tg-felg-T11309-Ag-1/ GM-Tg-felg-T11309-Ag-2; GM-Tg-cang-T11309-Ag-1/ GM-Tg-cang-T11309-Ag-2; GM-Tg-bovg-T11309-Ag-1/ GM-Tg-bovg-T11309-Ag-2; GM-Tg-equg-T11309-Ag-1/ GM-Tg-equg-T11309-Ag-2 |
| Products Name | MCP-1/CCL2 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | MCP-1/CCL2 |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MCP-1/CCL2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.